Keywords: diffuse large B‐cell lymphoma (DLBCL). Disclosures: Kurukulasuriya, N: Employment Leadership Position: MorphoSys US Inc. Menzler, J: Research Funding: Morphosys AG. Neubauer, A: Research Funding: Morphosys AG. Boehnke, A: Employment Leadership Position: MorphoSys AG....
摘要: PURPOSE: The therapeutic strategy for relapsed or refractory patients with diffuse large B-cell lymphoma (DLBL) remains challenging yet. Salvage therapy has been tried for these pa... 查看全部>>关键词:International Classification of Diseases Dexamethasone Cisplatin survival aspects 地塞米松 顺铂 ...
Current treatment of diffuse-large-B-cell lymphoma (DLBCL) includes rituximab, an expensive drug, combined with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy. Economic models have predicted rituximab plus CHOP (RCHOP) to be a cost-effective alternative to CHOP alone as...
doi:10.1200/JCO.2023.41.16_suppl.e195313e19531#Background:Central nervous system (CNS) relapse is an infrequent but serious and challenging complication in diffuse large B-cell lymphoma (DLBCL) that carries a dismal prognosis. While several risk factors have been identified to stratify the risk ...
The VHA is an equal access system providing a unique environment to investigate cancer disparities across the disease continuum.Methods:This is a retrospective chart review of 4033 randomly selected patients with an ICD code for lymphoma treated within the VHA between 01/01/2011 and 12/31/2017. ...
TO THE EDITOR Primary cutaneous diffuse large B-cell lymphoma leg type (PCDLBCL-LT) is a unique entity (ICD-O code 9680/3) individualized from other primary cutaneous B-cell lymphomas (PCBCL) and from nodal B-cell lymphomas by three main clinical features: preferential leg localization, ...
The therapeutic strategy for relapsed or refractory patients with diffuse large B-cell lymphoma (DLBL) remains challenging yet. Salvage therapy has been tried for these patients according to their clinical status. We studied ICD (irinotecan, cisplatin and dexamethasone) regimen as salvage chemotherapy ...
diffuse large B-cell lymphoma; follicular lymphoma; mediation analysis; epidemiology; comorbidity; survival1. Introduction Non-Hodgkin lymphoma (NHL) is a heterogeneous group of malignancies, two of the most common types are diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL). For ...